Profil
Mark J.
Murray was the founder of Protiva Biotherapeutics, Inc., founded in 2000, where the title held was President & Chief Executive Officer from 2000 to 2008.
The current job is Director at Genevant Sciences Corp.
Former job includes President, Chief Executive Officer & Director at Arbutus Biopharma Corp.
from 2011 to 2019.
Education includes a doctorate from Oregon Health & Science University.
Aktive Positionen von Mark Murray
| Unternehmen | Position | Beginn |
|---|---|---|
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mark Murray
| Unternehmen | Position | Ende |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Vorstandsvorsitzender | 24.06.2019 |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Vorstandsvorsitzender | 02.12.2008 |
Ausbildung von Mark Murray
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Oregon Health & Science University
Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
















